What Is The Largest Pharmacy Chain In The Us?

What Is The Largest Pharmacy Chain In The Us
According to a recent analysis from the Drug Channels Institute, the total income generated from the dispensing of prescription drugs at pharmacies in the United States reached a new high of $446 billion in 2019. A significant portion of this money was generated by CVS Health and Walgreens.

The following is a ranking of the 15 largest pharmacies in the United States in 2019, based on the total income generated from the dispensing of prescription drugs: 1. CVS Health, with 109 billion dollars in revenue 2. Walgreens — $84.3 billion 3. Cigna/Express Scripts — $45.8 billion 4. OptumRx, which is owned by UnitedHealth Group, is valued at $25.8 billion 5.

Walmart — $21.2 billion 6. The Kroger Company, with a revenue of $14.0 billion 7. Rite Aid, with a revenue of $11 billion 8. Humana Pharmacy Solutions, with a revenue of 6.9 billion dollars 9. Albertsons — $5.1 billion 10. Diplomat Pharmacy, with an annual revenue of $4.5 billion 11.

What is the biggest pharmacy chain in the US?

Drugstore franchises

Rank Pharmacy chain Stores
1 Walgreens Company 9,323
2 CVS Health 9,900
3 Walmart 4,865
4 Rite Aid Corp 2,721

Who’s bigger Walgreens or CVS?

Summary. Walgreens has a greater market share of the health and beauty specialty retail industry in the United States than CVS does, despite the fact that CVS is a larger firm in terms of sales and market capitalization.

What is the biggest pharmacy chain in the world?

According to research that was carried out on the 11th of December in 2017, Chongqing Tongjunge Drugstores Co. Ltd, which is based in China, is the largest chemist/pharmacy shop chain in terms of retail current, and it has 12,000 outlets in 2017. CVS Pharmacy in the United States is the second biggest network of chemists and pharmacies, with 9,706 locations.

What pharmacy fills the most prescriptions?

The 2022 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers will be made available for download by the Drug Channels Institute the following week. Our well-known and thorough investigation of the medication pricing, reimbursement, and dispensing system has now reached its thirteenth iteration and is in its thirteenth edition.

This initial look at the 15 largest organizations, ranked by total U.S. prescription dispensing revenues for the calendar year 2021 can be found in the exhibit that can be seen below, which is one of 216 that can be found in our new study. Revenues from the sale of prescription drugs in the United States hit a new high of $501 billion in 2021.

When compared to their share in 2020, the overall share held by the 15 largest firms is somewhat smaller now. This is mostly attributable to growth rates that are lower than average in the retail and long-term care pharmacy sectors. A reorganization of this list may take place in 2022 as a result of the impending changes in business that I will outline below.

  • Continue reading as we present our most recent informational update on the rapidly developing pharmacy and PBM business.
  • By clicking this link, you will be able to get a free summary of the full report, which will provide you with a look at the most important trends in the industry, the table of contents, and a list of the exhibits.
See also:  Why Did Tricare Drop Walmart Pharmacy?

If you place your purchase before the 28th of March in 2022, you will receive a special reduced price. Put them on the rack: THE TOP 15 The following table presents projections provided by DCI regarding the ranking of the major pharmacies for the year 2021 based on total revenues generated from the dispensing of prescription drugs, omitting income generated from the administration of COVID-19 vaccinations. In 2021, the top seven dispensing pharmacies in the United States were CVS Health, Walgreens Boots Alliance, Cigna, UnitedHealth Group, Walmart, and Kroger, and Rite Aid. These pharmacies accounted for more than 70 percent of the revenue generated from the sale of prescription drugs in the United States.

Nearly 77 percent of overall dispensing revenues came from retail, mail, long-term care, and specialty pharmacies, and those revenues were accounted for by the top 15 pharmacies. When compared with their share in 2020, the overall share held by the 15 largest firms was lower. This was mostly attributable to below-market growth rates seen by retail and long-term care pharmacies.

In the following parts of our new research, we address the market shifts and acquisitions that had an impact on the 2021 revenue and growth rates for the major companies: Section 2.3.3, Section 3.3.2, and Section 5.2.2. Analysis from previous years shows that five of the major pharmacies are controlled by pharmacy benefit managers (PBMs), including Caremark (CVS Health), Express Scripts (Cigna), Envolve Health (Centene), Humana, and OptumRx.

  • These pharmacies include central-fill mail and specialty pharmacies (UnitedHealth Group).
  • The most prominent PBMs, specialty pharmacies, and insurers have recently merged their operations to become vertically integrated corporations.
  • The income amounts displayed in the chart located above are a compilation of the dispensing revenues generated by all of the organizations’ constituent businesses.

The dispensing of more expensive speciality pharmaceuticals, which accounted for more than 38% of the pharmacy industry’s prescription sales in 2021, is driving revenue growth at the pharmacies owned and operated by pharmacy benefit managers (PBMs). PBMs’ capacity to generate revenue through specialized pharmacy dispensing and payments from manufacturers, as we demonstrate in Section 11.2.3.

  1. of our latest study, has become critically important.
  2. Even when rebates are factored in, the percentage of a plan sponsor’s pharmacy benefit expenses that are attributable to specialty medications continues to be more than that percentage.
  3. As a result, PBMs and third-party payers have been more proactive in their management of speciality therapies.
See also:  How To Become A Nuclear Pharmacy Technician?

Despite this, the speciality market is on the verge of seeing huge shifts. Competition from biosimilar and generic versions of these treatments is expected to increase over the next few years, which will impact the market for biologic as well as traditional specialty pharmaceuticals.

The distribution of COVID-19 vaccinations has contributed to an increase in the sales and earnings of retail pharmacies. The distribution of COVID-19 vaccinations has been significantly aided by the participation of pharmacies. About 200 million doses of the COVID-19 vaccination were administered by retail pharmacies in 2021, and this number does not include the doses that were delivered as part of the long-term care pharmacy program.

During the first five weeks of the year 2022, pharmacies provided an additional around 29 million doses to patients. We estimate that total pharmacy revenues (and gross profits) from the administration of COVID-19 vaccinations were greater than $7.5 billion until the end of 2021.

This figure includes both sales and profits. The COVID-19 vaccinations contributed around fifty percent of a pharmacy’s total income, which was the operational profit. The prescription dispensing data that are listed above do not include income from the administration of COVID-19 vaccinations since this will allow for easier comparison with figures from prior years.

The following are some of the major firms that are anticipated to undergo organizational shifts between now and 2022: In order to become one of the leading specialized pharmacy operators, Centene has completed various acquisitions of other enterprises.

  • On the other hand, the business has plans to contract out the management of its PBM activities to a third party.
  • It is very possible that this will entail the sale of its speciality pharmaceutical assets.
  • It was just fifteen months ago that it bought PANTHERx Rare Pharmacy, but it appears that the company has already started the process of selling it.

As I forecasted the year before, Walgreens saw a decline in revenues from its specialty pharmacies in 2021, and I anticipate an even larger decline in 2022. AllianceRx Walgreens Prime (ARxWP) is no longer the exclusive option for Prime Therapeutics’ PBM beneficiaries when it comes to mail-order and specialty pharmacy services.

  • Many Prime’s plan sponsor clients have switched to Express Scripts.
  • Walgreens has estimated that the loss of these customers will result in a decrease in revenue for ARxWP of $8 billion in both 2021 and 2022.
  • (It should be noted that Walgreens also purchased Prime’s 45% ownership stake in ARxWP.) In addition to this, the specialty pharmacy coverage for the Federal Employee Program (FEP) was transferred back to CVS Health in January 2022.

Prime was not able to retain this business. According to our best estimates, ARxWP brought in around $3.7 billion in income from speciality sales in 2021 thanks to this arrangement. Our ranking of the top 15 will continue to change, but it is still too early to speculate on the order in which the firms will finish.

NOTES FOR NERDS It is possible that the statistics we have projected for the revenue from prescriptions do not correlate with the estimates from other public sources. Because of these reasons: On the basis of a calendar year, we have either calculated or estimated the data. Many publicly traded firms in the retail industry do not align their fiscal years with the calendar year.

Many corporations do not reveal prescription revenues. As a result, we have estimated the data using a number of different approaches and sources. We have made a variety of modifications, as mentioned in the footnotes to the chart that is located above, to account for the pro forma impact of mergers and acquisitions, in addition to specific client transfers, among the biggest PBMs.

  1. These footnotes are located above the table.
  2. Additionally, year-over-year growth rates were calculated using the preceding year’s pro forma sales as the basis for comparison.
  3. When calculating pro forma revenues, the year in which a merger or acquisition was finalized is used as the base year.
  4. The numbers for prescription dispensing revenues and profits in our new report (including the table above) do not include COVID-19 vaccines that were provided in retail pharmacies.
See also:  What Is A Pharmacy Assistant Salary?

This is true unless it is specifically stated otherwise elsewhere in the report. This exclusion makes it possible to make comparisons with the statistics from earlier years that are more accurate. Another thing to keep in mind is that revenues from the dispensing of prescription drugs are not the same as the net spending on outpatient prescription drugs that is reported by the Centers for Medicare and Medicaid Services, nor are they the same as “non-discounted spending” or “invoice-price spending” (reported by IMS Health).

Who has the most pharmacies in the US?

What Is The Largest Pharmacy Chain In The Us The following is a list of the 10 pharmacies in the United States that have the most locations and so are considered to be the largest: – In 2022, CVS Pharmacy, Walgreens, and Health Mart will have the most locations across the United States, making them the three largest pharmacies in the country.

  • The most sites are found within the CVS Pharmacy chain, which has 9,770 outlets spread over 52 states and territories.
  • In the United States, Walgreens has 8,890 stores, whereas Health Mart has 4,685 outlets.
  • These three establishments account for a combined total of 71.82% of the top 10 pharmacies in the United States.

THE LARGEST PHARMACY IN 19 OF THE 56 STATES AND TERRITORIES IN THE UNITED STATES OF AMERICA. THE LARGEST PHARMACY IN 18 OF THE 56 STATES AND TERRITORIES IN THE UNITED STATES OF AMERICA. THE LARGEST PHARMACY IN NINE OF THE 56 STATES AND TERRITORIES IN THE UNITED STATES OF AMERICA